Intra-Cellular Therapies Inc’s recent filing unveils that its Director ALEXANDRIA VENTURE INVESTMENTS acquired Company’s shares for reported $1.83 million on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Intra-Cellular Therapies
Intra-Cellular Therapies Inc’s filing revealed that its Director ALEXANDRIA VENTURE INVESTMENTS acquired Company’s shares for reported $1.83 million on Sep
Intra-Cellular Therapies Inc’s recently made public that its Director ALEXANDRIA VENTURE INVESTMENTS acquired Company’s shares for reported $1.83 million on
In a filing, Intra-Cellular Therapies Inc revealed its Director ALEXANDRIA VENTURE INVESTMENTS acquired Company’s shares for reported $1.83 million on
Intra-Cellular Therapies Inc’s recent filing unveils that its Director ALEXANDRIA VENTURE INVESTMENTS acquired Company’s shares for reported $1.83 million on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Intra-Cellular Therapies
Intra-Cellular proposes $350 million underwritten public offering. In addition, with the update of positive final-phase test results for a treatment
